Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Array Technology Could Screen for Emerging Viral Diseases

Published: Wednesday, July 16, 2014
Last Updated: Wednesday, July 16, 2014
Bookmark and Share
A microbe detection array technology could provide a new rapid method for public health authorities to conduct surveillance for emerging viral diseases.

This possible use of the Lawrence Livermore Microbial Detection Array (LLMDA) was studied by an international team of researchers from eight nations in a paper published late last month in the PLOS ONE scientific journal.

"The disease symptoms for emerging viruses are often similar to those of other more common viruses, posing a diagnostic challenge to clinicians unfamiliar with the novel organism," the authors wrote. "In the case of emerging viruses, it is crucial for patient treatment and for containment of a potential epidemic to quickly identify the correct virus."

With the use of the LLMDA, combined with a DNA amplification technique developed by researchers from Denmark, the team was able to correctly identify 29 different emerging viruses in both clinical and non-clinical samples.

One of LLMDA's most important advantages is that the tool can perform thousands of tests in parallel within 24 hours, while another method, polymerase chain reaction (PCR) -- though faster -- can only run dozens of tests at a time.

The paper's lead author is a researcher from the Copenhagen-based Statens Serum Institut, Denmark's equivalent of the United States' Centers for Disease Control and Prevention (CDC).

Two LLNL scientists -- bioinformaticist Shea Gardner, who designed the array, and biostatistician Kevin McLoughlin, who designed the analysis algorithm -- were members of the team.

"The study shows that we are moving closer to having a robust technology that can be used for surveillance of emerging diseases," McLoughlin said. "It could be used in public health laboratories to screen samples for viruses that are unexpected in the population."

Emerging viruses are normally endemic to tropical and sub-tropical regions of the world, but increased global travel and other factors are believed to contribute to the spread of these viruses into new regions.

In the view of the paper's authors, the risk of importing rare, exotic and emerging diseases to Europe has increased.

"Some areas in Europe already maintain environmental conditions favorable to these pathogens, such as hantavirus, Crimean-Congo hemorrhagic fever virus and West Nile virus. Travelers visiting endemic areas are a potential source for spreading these diseases," the authors said.

"There is a demand," they noted, "for rapid and accurate identification of the virus to initiate specific treatment, if available, as well as appropriate case management, such as isolation and contact tracking."

The authors reported that they found the LLMDA to be sensitive and specific to a wide range of emerging viruses and to successfully identify emerging viruses present in clinical samples.

Among the viruses detected in the clinical samples were: Dengue fever, West Nile, Crimean-Congo hemorrhagic fever, Chikungunya, polyomaviruses, herpes simplex, hepatitis GB virus C and Coxsackie.

The only sample in the study that was not identified was a Dengue fever virus, in which the viral concentration was determined to be below the detection limit. However, seven other clinical samples tested with Dengue fever virus were detected.

In the study, the team used an earlier version of the LLMDA that contained some 388,000 probes that could detect 2,195 viruses and 924 bacteria.

The current version of the array, with 180,000 probes, can identify 4,377 viruses and 5,457 bacteria, as well as a combined total of more than 775 protozoa, fungi and archaea species.

Developed in 2008, the LLMDA detects microbes with the use of probes that fit in a checkerboard pattern in the middle of a 1-inch wide, 3-inch long glass slide. The instrument is seen as occupying a niche role between PCR and sequencing.

The LLMDA process starts with the purification of DNA or RNA from a sample, such as sputum or blood. The sample is next labeled with a fluorescent dye and hybridized on the microarray at 42 degrees Celsius or about 107.6 degrees Fahrenheit. In turn, a fluorescent scanner and analysis software are used to detect the probes that have lit up, identifying the presence of viral or bacterial sequences.

Other institutions that participated in the research included: Aristotle University of Thessaloniki (Greece), Spiez Laboratory (Spiez, Switzerland), the French Army Forces Biomedical Institute (Marseille, France), the Swedish Institute for Communicable Disease Control (Solna, Sweden), the National Veterinary Institute (Uppsala, Sweden), Linkoping University (Linkoping, Sweden); the University of Stirling (the United Kingdom), Robert Koch Institute (Berlin, Germany) and the University of Southern Denmark (Odense, Denmark).     

The PLOS ONE paper, entitled "The Microbial Detection Array for Detection of Emerging Viruses in Clinical Samples - A Useful Panmicrobial Diagnostic Tool," can be found online.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Ultrafast DNA Diagnostics
New technology developed by UC Berkeley bioengineers promises to make a workhorse lab tool cheaper, more portable and many times faster by accelerating the heating and cooling of genetic samples with the switch of a light.
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!